Zenomics Company
Zenomics is developing a microneedle transdermal patch technology for diabetes, which is able to sense blood glucose levels and respond with appropriate concentrations of insulin. The company's drug delivery patch senses blood glucose levels and responds with appropriate concentrations of insulin. The company was founded in 2015 and is headquartered in Durham, North Carolina.
Technology:
Health Monitoring
Industry:
P4 Medicine
Headquarters:
Durham, North Carolina, United States
Zip:
1-10
Founded Date:
2015-09-01
Employees Number:
1-10
Investors Number:
2800160
Total Funding:
$100M to $500M
Estimated Revenue:
$100M to $500M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
info@Zenomicsbio.com
Register and Claim Ownership